Diagnostic Technology

Our breakthrough diagnostics technology is based on the assumption that pluripotent stem cells , residing in multiple tissues, undergo epigenetic changes and get transformed into CSCs. In cancer patients, these cells from the impacted organs in the body get mobilized into circulation in increased numbers and can be detected by the HrC test.

The HrC test

HrC detects cancer using genetic markers, not at the tumour cell level, but at the seed stage i.e, cancer stem cell level. It tests for the proliferation of cancer cells and hence determines cancer absence or likelihood of presence (from negligible to high).

This critical discovery utilizes peripheral blood and is non-intrusive unlike tissue biopsies.

Consequently, the detection of cancer at stage zero increases the chances of survival significantly, as well as decreasing the time and cost of treatment.

Book an HrC test